BF Biosciences Limited (PSX:BFBIO)
Pakistan · Delayed Price · Currency is PKR 130.90
-1.72 (-1.30%)
At close: Nov 6, 2026
BF Biosciences Cash Flow Statement
Financials in millions PKR. Fiscal year is July - June.
Millions PKR. Fiscal year is Jul - Jun.
Operating Activities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Net Income | 657.49 | 632.13 | 447.15 | 385.41 | 149.05 | 306.98 |
Depreciation & Amortization | 281.55 | 273.58 | 191.92 | 35.57 | 33.78 | 28 |
Other Amortization | 2.27 | 1.85 | 1.69 | 0.55 | 0.55 | - |
Loss (Gain) From Sale of Assets | -3.67 | -2.99 | -2.79 | -2.13 | -1.06 | - |
Loss (Gain) From Sale of Investments | -69.39 | -93.89 | -27.3 | -0.21 | -8.93 | - |
Provision & Write-off of Bad Debts | 4.57 | 4.57 | -14.28 | - | - | - |
Other Operating Activities | 343.48 | 300.82 | 56.07 | 305.49 | 32.12 | -156.98 |
Change in Accounts Receivable | 31.46 | -169.4 | 27.99 | -110.82 | -41.1 | - |
Change in Inventory | -1,262 | -1,363 | -858.15 | -41.57 | -445.69 | - |
Change in Accounts Payable | 280.02 | 432.36 | 472.43 | 196.75 | -5.94 | - |
Change in Unearned Revenue | 67.63 | 22.36 | -5.27 | 19.75 | -17.78 | - |
Change in Other Net Operating Assets | -161.31 | -64.9 | 10.32 | -124.09 | 108.94 | - |
Operating Cash Flow | 171.8 | -26.51 | 299.79 | 664.7 | -196.07 | 178 |
Operating Cash Flow Growth | -40.98% | - | -54.90% | - | - | -68.77% |
Investing Activities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Capital Expenditures | -854.54 | -603.06 | -324.37 | -143.13 | -1,968 | -1,130 |
Sale of Property, Plant & Equipment | 7.19 | 6.49 | 3.86 | 4.4 | 1.06 | - |
Sale (Purchase) of Intangibles | -5.09 | -5.09 | -5.12 | - | -1.66 | - |
Investment in Securities | 1,049 | 949.56 | -1,100 | 108.58 | 1,161 | - |
Other Investing Activities | -77.86 | -74.65 | 91 | 16.34 | 83.4 | -333 |
Investing Cash Flow | 119.08 | 273.25 | -1,335 | -13.81 | -724.44 | -1,463 |
Financing Activities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Short-Term Debt Issued | - | 206.21 | - | - | - | - |
Long-Term Debt Issued | - | - | 93.55 | - | 811.02 | - |
Total Debt Issued | 206.21 | 206.21 | 93.55 | - | 811.02 | - |
Short-Term Debt Repaid | - | - | -231.86 | - | - | - |
Long-Term Debt Repaid | - | -442.52 | -436.19 | -321.36 | -50.5 | - |
Total Debt Repaid | -443.31 | -442.52 | -668.04 | -321.36 | -50.5 | - |
Net Debt Issued (Repaid) | -237.09 | -236.31 | -574.49 | -321.36 | 760.52 | - |
Issuance of Common Stock | - | - | 1,855 | - | - | - |
Other Financing Activities | -83.35 | -83.52 | -112.25 | -161.52 | -120.28 | 925 |
Financing Cash Flow | -320.44 | -319.84 | 1,168 | -482.88 | 640.24 | 925 |
Net Cash Flow
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Miscellaneous Cash Flow Adjustments | - | - | - | - | - | 1 |
Net Cash Flow | -29.57 | -73.09 | 133.18 | 168.02 | -280.27 | -359 |
Free Cash Flow
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -682.75 | -629.57 | -24.59 | 521.57 | -2,164 | -952 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -6.96% | -6.65% | -0.42% | 14.26% | -119.61% | -62.60% |
Free Cash Flow Per Share | -7.72 | -7.13 | -0.30 | 8.23 | -34.17 | -15.03 |
Levered Free Cash Flow | -898.25 | -783.86 | -254.99 | 313.25 | -2,306 | -834 |
Unlevered Free Cash Flow | -841.69 | -729.61 | -185.18 | 400.58 | -2,306 | -792.99 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash Interest Paid | 83.35 | 83.52 | 112.25 | 161.52 | 120.28 | - |
Cash Income Tax Paid | 273.93 | 310.69 | 282.25 | 51.39 | 73.4 | - |
Change in Working Capital | -1,044 | -1,143 | -352.68 | -59.98 | -401.58 | - |